Skip to main content
Evidentli banner
Evidentli logo

Evidentli

Evidentli is a medical software company.

Backed by

InvestibleInvestible
Australian Medical AngelsAustralian Medical Angels
Black NovaBlack Nova
HNW investorsHNW investors
HealthCare VenturesHealthCare Ventures

EQUITY on April 13, 2023

About

Evidentli provides Piano, an AI/ML platform that extracts evidence from diverse healthcare data to accelerate clinical evidence generation and support decision-making across research teams on multiple continents.

Mission

Evidentli's flagship product, Piano, leverages AI and machine learning to extrapolate insights from healthcare data to inform evidence-based decisions far more quickly than traditional research teams. The platform is positioned to address the gap the company describes as healthcare being ""data-rich but evidence-poor."" Investible announced it welcomed Guy Tsafnat PhD FAIDH, Enrico Coiera, Alison Gartner, Greg Miner and the whole Evidentli team into its portfolio at the end of last year. Investible's Early Stage Fund 2 and Club Investible participated in the investment alongside Black Nova Venture Capital, Australian Medical Angels, Healthcare Ventures LP and HNW investors. Evidentli says it is now operating on four continents and is growing quickly. The company highlights ongoing support from Investible as part of its expansion.

Quick Facts

Founded

2018

Funding

EQUITY

Industry

Health Care, Medical, Software

Team Size

11-50

Headquarters

Sydney, New South Wales, Australia